Neuroimaging Correlates of Patient-Reported Outcomes in Multiple Sclerosis

References

• Thompson AJ, Baranzini SE, Geurts J, Hemmer B, Ciccarelli O. Multiple sclerosis. Lancet. 2018;391(10130):1622–1636. doi:10.1016/S0140-6736(18)30481-1
   PubMed Web of Science ®Google Scholar
• Young CA, Mills R, Rog D, et al. Quality of life in multiple sclerosis is dominated by fatigue, disability and self-efficacy. J Neurol Sci. 2021;426:117437. doi:10.1016/j.jns.2021.117437
   PubMed Web of Science ®Google Scholar
• Lakin L, Davis BE, Binns CC, Currie KM, Rensel MR. Comprehensive approach to management of multiple sclerosis: addressing invisible symptoms-a narrative review. Neurol Ther. 2021;10:75–98. doi:10.1007/s40120-021-00239-2
   PubMed Web of Science ®Google Scholar
• Hanna M, Strober LB. Anxiety and depression in Multiple Sclerosis (MS): antecedents, consequences, and differential impact on well-being and quality of life. Mult Scler Relat Disord. 2020;44:102261. doi:10.1016/j.msard.2020.102261
   PubMed Web of Science ®Google Scholar
• Kurtzke JF. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology. 1983;33(11):1444–1452. doi:10.1212/WNL.33.11.1444
   PubMed Web of Science ®Google Scholar
• Motl RW, Cohen JA, Benedict R, et al. Validity of the timed 25-foot walk as an ambulatory performance outcome measure for multiple sclerosis. Mult Scler. 2017;23:704–710. doi:10.1177/1352458517690823
   PubMed Web of Science ®Google Scholar
• Feys P, Lamers I, Francis G, et al. The nine-hole peg test as a manual dexterity performance measure for multiple sclerosis. Mult Scler. 2017;23:711–720. doi:10.1177/1352458517690824
   PubMed Web of Science ®Google Scholar
• Benedict RHB, Amato MP, DeLuca J, Geurts JJG. Cognitive impairment in multiple sclerosis: clinical management, MRI, and therapeutic avenues. Lancet Neurol. 2020;19:860–871. doi:10.1016/S1474-4422(20)30277-5
   PubMed Web of Science ®Google Scholar
• Vaughn CB, Jakimovski D, Kavak KS, et al. Epidemiology and treatment of multiple sclerosis in elderly populations. Nat Rev Neurol. 2019;15(6):329–342. doi:10.1038/s41582-019-0183-3
   PubMed Web of Science ®Google Scholar
• Fischer JS, Rudick RA, Cutter GR, Reingold SC. The Multiple Sclerosis Functional Composite Measure (MSFC): an integrated approach to MS clinical outcome assessment. National MS society clinical outcomes assessment task force. Mult Scler. 1999;5:244–250. doi:10.1177/135245859900500409
   PubMed Web of Science ®Google Scholar
• Weideman AM, Barbour C, Tapia-Maltos MA, et al. New multiple sclerosis disease severity scale predicts future accumulation of disability. Front Neurol. 2017;8:598. doi:10.3389/fneur.2017.00598
   PubMed Web of Science ®Google Scholar
• Cella D, Lai JS, Nowinski CJ, et al. Neuro-QOL: brief measures of health-related quality of life for clinical research in neurology. Neurology. 2012;78:1860–1867. doi:10.1212/WNL.0b013e318258f744
   PubMed Web of Science ®Google Scholar
• Gershon RC, Lai JS, Bode R, et al. Neuro-QOL: quality of life item banks for adults with neurological disorders: item development and calibrations based upon clinical and general population testing. Qual Life Res. 2012;21(3):475–486. doi:10.1007/s11136-011-9958-8
   PubMed Web of Science ®Google Scholar
• Goverover Y, Kalmar J, Gaudino-Goering E, et al. The relation between subjective and objective measures of everyday life activities in persons with multiple sclerosis. Arch Phys Med Rehabil. 2005;86(12):2303–2308. doi:10.1016/j.apmr.2005.05.016
   PubMed Web of Science ®Google Scholar
• Ozel O, Vaughn CB, Eckert SP, Jakimovski D, Lizarraga AA, Weinstock-Guttman B. Dimethyl fumarate in the treatment of relapsing-remitting multiple sclerosis: patient reported outcomes and perspectives. Patient Relat Outcome Meas. 2019;10:373–384. doi:10.2147/PROM.S168095
   PubMed Web of Science ®Google Scholar
• Greenhalgh J, Gooding K, Gibbons E, et al. How do patient reported outcome measures (PROMs) support clinician-patient communication and patient care? A realist synthesis. J Patient Rep Outcomes. 2018;2:42. doi:10.1186/s41687-018-0061-6
   PubMedGoogle Scholar
• Nowinski CJ, Miller DM, Cella D. Evolution of patient-reported outcomes and their role in multiple sclerosis clinical trials. Neurotherapeutics. 2017;14(4):934–944. doi:10.1007/s13311-017-0571-6
   PubMed Web of Science ®Google Scholar
• Granger C. The LIFEware system^ s^ m. J Rehabil Outcomes Meas. 1999;3:63–69.
   Google Scholar
• Jakimovski D, Ramasamy DP, Zivadinov R. Magnetic resonance imaging and analysis in multiple sclerosis. In: Rizvi SA, Cahill JF, Coyle PK, editors. Clinical Neuroimmunology: Multiple Sclerosis and Related Disorders. Cham: Springer International Publishing; 2020:109–136.
   Google Scholar
• Uher T, Krasensky J, Sobisek L, et al. Cognitive clinico-radiological paradox in early stages of multiple sclerosis. Ann Clin Transl Neurol. 2018;5(1):81–91. doi:10.1002/acn3.512
   PubMed Web of Science ®Google Scholar
• Barkhof F. The clinico-radiological paradox in multiple sclerosis revisited. Curr Opin Neurol. 2002;15(3):239–245. doi:10.1097/00019052-200206000-00003
   PubMed Web of Science ®Google Scholar
• Lublin FD, Reingold SC, Cohen JA, et al. Defining the clinical course of multiple sclerosis: the 2013 revisions. Neurology. 2014;83(3):278–286. doi:10.1212/WNL.0000000000000560
   PubMed Web of Science ®Google Scholar
• Ottenbacher KJ, Mann WC, Granger CV, Tomita M, Hurren D, Charvat B. Inter-rater agreement and stability of functional assessment in the community-based elderly. Arch Phys Med Rehabil. 1994;75(12):1297–1301. doi:10.1016/0003-9993(94)90276-3
   PubMed Web of Science ®Google Scholar
• Baker JG, Granger CV, Fiedler RC. A brief outpatient functional assessment measure: validity using rasch measures. Am J Phys Med Rehabil. 1997;76(1):8–13. doi:10.1097/00002060-199701000-00003
   PubMed Web of Science ®Google Scholar
• Granger CV, Cotter AC, Hamilton BB, Fiedler RC. Functional assessment scales: a study of persons after stroke. Arch Phys Med Rehabil. 1993;74(2):133–138.
   PubMed Web of Science ®Google Scholar
• Mithal M, Mann WC, Granger CV. The role of Coronary Heart Disease (CHD) in functional limitation in community dwelling elders. Phys Occup Ther Geriatr. 2001;19(3):35–48. doi:10.1080/J148v19n03_03
   Google Scholar
• Jakimovski D, Weinstock-Guttman B, Hagemeier J, et al. Walking disability measures in multiple sclerosis patients: correlations with MRI-derived global and microstructural damage. J Neurol Sci. 2018;393:128–134. doi:10.1016/j.jns.2018.08.020
   PubMed Web of Science ®Google Scholar
• Gelineau-Morel R, Tomassini V, Jenkinson M, Johansen-Berg H, Matthews PM, Palace J. The effect of hypointense white matter lesions on automated gray matter segmentation in multiple sclerosis. Hum Brain Mapp. 2012;33(12):2802–2814. doi:10.1002/hbm.21402
   PubMed Web of Science ®Google Scholar
• Mowry EM, Beheshtian A, Waubant E, et al. Quality of life in multiple sclerosis is associated with lesion burden and brain volume measures. Neurology. 2009;72(20):1760–1765. doi:10.1212/WNL.0b013e3181a609f8
   PubMed Web of Science ®Google Scholar
• Fritz NE, Roy S, Keller J, Prince J, Calabresi PA, Zackowski KM. Pain, cognition and quality of life associate with structural measures of brain volume loss in multiple sclerosis. NeuroRehabilitation. 2016;39(4):535–544. doi:10.3233/NRE-161384
   PubMed Web of Science ®Google Scholar
• Conway DS, Thompson NR, Meng X, Johnson K, Fox RJ. Patient reported outcomes and performance metrics at diagnosis of secondary progressive multiple sclerosis. Mult Scler. 2021;27(5):742–754. doi:10.1177/1352458520936214
   PubMed Web of Science ®Google Scholar
• Healy BC, Zurawski J, Chitnis T, Weiner HL, Glanz BI. Patient-reported outcomes associated with transition to secondary progressive multiple sclerosis. Qual Life Res. 2022;31(6):1799–1805. doi:10.1007/s11136-021-03034-6
   PubMed Web of Science ®Google Scholar
• Vaughn CB, Kavak KS, Dwyer MG, et al. Fatigue at enrollment predicts EDSS worsening in the New York state multiple sclerosis consortium. Mult Scler J. 2020;26(1):99–108. doi:10.1177/1352458518816619
   PubMed Web of Science ®Google Scholar
• Kletenik I, Alvarez E, Honce JM, Valdez B, Vollmer TL, Medina LD. Subjective cognitive concern in multiple sclerosis is associated with reduced thalamic and cortical gray matter volumes. Mult Scler J Exp Transl Clin. 2019;5(1):2055217319827618. doi:10.1177/2055217319827618
   Google Scholar
• Macaron G, Baldassari LE, Nakamura K, et al. Cognitive processing speed in multiple sclerosis clinical practice: association with patient-reported outcomes, employment and magnetic resonance imaging metrics. Eur J Neurol. 2020;27(7):1238–1249. doi:10.1111/ene.14239
   PubMed Web of Science ®Google Scholar
• Bergsland N, Benedict RHB, Dwyer MG, et al. Thalamic nuclei volumes and their relationships to neuroperformance in multiple sclerosis: a cross-sectional structural MRI study. J Magn Reson Imaging. 2021;53:731–739. doi:10.1002/jmri.27389
   PubMed Web of Science ®Google Scholar
• Glukhovsky L, Brandstadter R, Leavitt VM, et al. Hippocampal volume is more related to patient-reported memory than objective memory performance in early multiple sclerosis. Mult Scler. 2021;27(4):568–578. doi:10.1177/1352458520922830
   PubMed Web of Science ®Google Scholar
• Vaughn C, Kavak KS, Jakimovski D, et al. Patient-reported outcomes are the strongest predictors of disease disability in intramuscular interferon beta-1a users. Neurodegener Dis Manag. In Press 2023.
   PubMed Web of Science ®Google Scholar
• Manchon E, Laplaud D, Vukusic S, et al. Efficacy, safety and patient reported outcomes in patients with active relapsing multiple sclerosis treated with ocrelizumab: final results from the PRO-MSACTIVE study. Mult Scler Relat Disord. 2022;68:104109. doi:10.1016/j.msard.2022.104109
   PubMed Web of Science ®Google Scholar
• Beleckas CM, Guattery J, Chamberlain AM, Khan T, Kelly MP, Calfee RP. Using patient-reported outcomes measurement information system measures to understand the relationship between improvement in physical function and depressive symptoms. J Am Acad Orthop Surg. 2018;26(24):e511–e518. doi:10.5435/JAAOS-D-17-00039
   PubMed Web of Science ®Google Scholar
• Callahan CM, Kroenke K, Counsell SR, et al. Treatment of depression improves physical functioning in older adults. J Am Geriatr Soc. 2005;53(3):367–373. doi:10.1111/j.1532-5415.2005.53151.x
   PubMed Web of Science ®Google Scholar
• Fuchs TA, Vaughn CB, Benedict RHB, et al. Patient-reported outcome severity and emotional salience network disruption in multiple sclerosis. Brain Imaging Behav. 2022;16:1252–1259. doi:10.1007/s11682-021-00614-5
   PubMed Web of Science ®Google Scholar
• van Geest Q, Boeschoten RE, Keijzer MJ, et al. Fronto-limbic disconnection in patients with multiple sclerosis and depression. Mult Scler. 2019;25:715–726. doi:10.1177/1352458518767051
   PubMedGoogle Scholar
• Ashton K, Fuchs TA, Oship D, et al. Diagnosis of depression in multiple sclerosis is predicted by frontal-parietal white matter tract disruption. J Neurol. 2021;268:169–177. doi:10.1007/s00415-020-10110-3
   PubMed Web of Science ®Google Scholar
• Healy BC, Buckle GJ, Ali EN, et al. Characterizing clinical and MRI dissociation in patients with multiple sclerosis. J Neuroimaging. 2017;27:481–485. doi:10.1111/jon.12433
   PubMed Web of Science ®Google Scholar
• Kosmidis MH, Bozikas VP, Giannouli V, Karavatos A, Fokas K. Familial comorbidity of bipolar disorder and multiple sclerosis: genetic susceptibility, coexistence or causal relationship? Behav Neurol. 2012;25:341–349. doi:10.1155/2012/894128
   PubMed Web of Science ®Google Scholar
• Younus Z, Vaughn CB, Sanai SA, et al. Fatigue and mood states in nursing home and nonambulatory home-based patients with multiple sclerosis. Int J MS Care. 2017;19:297–302. doi:10.7224/1537-2073.2016-058
   PubMedGoogle Scholar
• Grothe M, Gross S, Süße M, Strauss S, Penner IK. The seasonal fluctuation of fatigue in multiple sclerosis. Front Neurol. 2022;13. doi:10.3389/fneur.2022.900792
   Web of Science ®Google Scholar
• Romberg A, Ikonen A, Ruutiainen J, Virtanen A, Hämäläinen P. The effects of heat stress on physical functioning in persons with multiple sclerosis. J Neurol Sci. 2012;319:42–46. doi:10.1016/j.jns.2012.05.024
   PubMed Web of Science ®Google Scholar
• Calvert MJ, Cruz Rivera S, Retzer A, et al. Patient reported outcome assessment must be inclusive and equitable. Nat Med. 2022;28:1120–1124. doi:10.1038/s41591-022-01781-8
   PubMed Web of Science ®Google Scholar
• Theofilou P, Giannouli V, Kolias S, Tsolaki M. Perception of pain self-efficacy and fatigue in Greek patients with multiple sclerosis: a study protocol. Health Psychol Res. 2015;3:1556. doi:10.4081/hpr.2015.1556
   PubMedGoogle Scholar
• Westerlind H, Boström I, Stawiarz L, Landtblom AM, Almqvist C, Hillert J. New data identify an increasing sex ratio of multiple sclerosis in Sweden. Mult Scler. 2014;20:1578–1583. doi:10.1177/1352458514530021
   PubMed Web of Science ®Google Scholar
• Zurawski J, Glanz BI, Healy BC, et al. The impact of cervical spinal cord atrophy on quality of life in multiple sclerosis. J Neurol Sci. 2019;403:38–43. doi:10.1016/j.jns.2019.04.023
   PubMed Web of Science ®Google Scholar